-
Forward Look
Targeted ChemotherapyComputational and molecular biologist Sourav Bandyopadhyay discusses new ways to think about chemotherapy.
by Sue Rochman
-
Healthy Habits
Go FishWhy replacing red meat with fish may be just what the doctor ordered.
by Brenda Conaway
-
Healthy Habits
Against the ClockNight shift work may contribute to a heightened cancer risk.
by Jane C. Hu
-
From the Editor-in-Chief
CAR-T Cells: ‘Bionic’ Immune Cells for Treating CancerT cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
-
Forward Look
Drug Combo Targets Polyp GrowthStudy findings support precision approaches to risk reduction.
by Dara Chadwick
-
Forward Look
Cloning CancerScientists are testing treatments on lab-grown tumor tissue.
by Chris Palmer
-
-
New Tactics for Bladder CancerAfter decades without treatment advances, options for patients with bladder cancer are now more numerous.
by Kendall K. Morgan
-
The Roots of Rural Health DisparitiesNew research shows that rural cancer patients have the same health outcomes as urban cancer patients so long as they are involved in a clinical trial.
by Cheryl Platzman Weinstock
-
The Health Legacy of 9/11People who were directly affected by the Sept. 11 terrorist attacks can receive screenings and care for medical conditions, including certain cancers, through the World Trade Center Health Program.
by Brad Jones
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
